 |
BioWorld-International-2007-12-05
$1 Billion Deal With Novartis Opens Options For Morphosys
$1 Billion Deal With Novartis Opens Options For Morphosys
During the first half of 2008, Morphosys AG plans to set out the shape of its future drug development strategy, following its mega-scale antibody discovery and development deal with Novartis AG, which the company estimates will deliver $1 billion in cash over the next 10 years. (BioWorld International)